SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

For gene therapy to work well, therapeutic molecules need to be efficiently delivered to the correct locations in the body—a job commonly given to adeno-associated viruses (AAV). To improve the AAV’s ...

A new nasal spray-based gene therapy, using AAV.CPP.16 shows promise for treating lung diseases like COVID-19 and pulmonary fibrosis. Scientists engineered a way to deliver genes directly to lung and ...

August 2, 2012 — A spray formulation of allogeneic neonatal keratinocytes and fibroblasts heals venous leg ulcers without the need for tissue engineering. The spray-applied cell therapy is dosed at ...